The commercial flagship of the line is Cruise Chews. Unlike black-market or high-octane dispensary edibles that push 50 to 100 milligrams of pure THC per package, Cruise Chews rely on a deliberate cannabinoid synergy. Each gummy typically contains 30mg of cannabidiol (CBD) paired with 3mg of Delta-9 THC, alongside trace amounts of secondary cannabinoids like CBG and CBN extracted from full spectrum hemp extract.
+-----------------------------------------------------------+
+-----------------------------------------------------------+
This 10:1 CBD to THC ratio leverages the entourage effect while muting the unwanted side effects of THC intoxication:
- Receptor Modulation: CBD acts as a negative allosteric modulator of the human CB1 cannabinoid receptor in the central nervous system. When consumed together, CBD alters the physical shape of the receptor, weakening the binding affinity of Delta-9 THC.
- Mitigated Psychoactivity: The 3mg dose of THC delivers a warm, sensory-enhancing effect, but the dominant 30mg payload of CBD buffers against racing thoughts, cognitive disorientation, or acute paranoia.
- Physical Relaxation: Full spectrum hemp components target peripheral CB2 receptors, reducing physical tension and somatic stress markers without immobilizing the user on the couch.
Natural fruit terpenes are re-infused into the gummy pectin matrix during production. Rather than tasting purely like artificial confectioner's sugar or bitter, burnt hash oil, these gummies retain floral, citrus, and berry notes that mirror raw plant profiles. The resulting high is subtle, functional, and distinctly non-disruptive to daily responsibilities.
